Merck hit with $285,000 verdict in Fosamax trial NEW YORK, Feb 5 (Reuters) - A federal jury on Tuesday ordered Merck & Co Inc to pay $285,000 in a lawsuit over the risks of its osteoporosis drug Fosamax , the second loss for the company after several earlier trials. The eight-person jury in U.S. ... [News Source]